| [1] |
CAO Yue, SUN Qijuan, WANG Su, PAN Yiru, WANG Shiwen.
Reference range of serum cystatin C in elders in Shanghai
[J]. Laboratory Medicine, 2025, 40(8): 731-734.
|
| [2] |
CHEN Yanqin, FAN Lina, YANG Dagan.
Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis
[J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
|
| [3] |
LOU Zhan, PENG Tao, LIU Xingliang, YUE Binghong, LI Ran, ZHI Yongyi.
Changes of serum NFL，Cys C and Lp-PLA2 levels in patients with vascular Parkinsonism and their clinical significance
[J]. Laboratory Medicine, 2024, 39(9): 828-833.
|
| [4] |
CHEN Haiying, GE Yafang, PAN Shun, YANG Haiou.
Clinical value of inflammatory derived indicators and cystatin C in preeclampsia
[J]. Laboratory Medicine, 2024, 39(6): 557-561.
|
| [5] |
YU Jiahui, ZHOU Lin, GUO Gang, ZHOU Jianmei.
Relationship between serum homocysteine，cystatin C levels and cognitive impairment in patients with herpes simplex encephalitis
[J]. Laboratory Medicine, 2024, 39(4): 393-399.
|
| [6] |
ZHU Qinghua, WANG Weiwei, ZOU Guanghui, DONG Zhiwu.
Combined detection of serum NGAL and Cys C in the diagnosis of early nephropathy in patients with type 2 diabetes mellitus
[J]. Laboratory Medicine, 2021, 36(3): 281-284.
|
| [7] |
ZHANG Ke, TONG Shutao, ZHANG Detai.
Correlation between serum thyroid hormones and Cr and Cys C in patients with initial thyroid dysfunction
[J]. Laboratory Medicine, 2020, 35(7): 691-694.
|
| [8] |
CHEN Jun.
Correlation between cystatin C,α-klotho protein,sICAM-1 and diabetic nephropathy
[J]. Laboratory Medicine, 2020, 35(10): 1032-1035.
|
| [9] |
YI Xuejun, ZHANG Ailing, ZHAI Jianxin.
Changes and correlation of serum cystatin C and myeloperoxidase levels in patients with coronary slow-flow angina pectoris
[J]. Laboratory Medicine, 2018, 33(3): 191-195.
|
| [10] |
ZHANG Rulin, WANG Hongming, PENG Xia, LI Jiayong, LI Li.
Combined determination of serum amyloid A protein,cystatin C and urinary albumin-to-creatinine ratio in the diagnosis of early diabetic nephropathy
[J]. Laboratory Medicine, 2018, 33(2): 97-100.
|
| [11] |
YUE Xiaojing, LI Wei, LI Pingfa.
Determination of paraquat in plasma by HPLC-MS/MS
[J]. Laboratory Medicine, 2018, 33(2): 132-138.
|
| [12] |
LI Jiangfeng, FENG Minyi, QIAN Wei, ZHAO Xiaoni, CHEN Zitong, JIAO Liyuan, WANG Jihua, CAI Lei.
Preparation and performance of recombinant human cystatin C quality control material
[J]. Laboratory Medicine, 2017, 32(8): 733-737.
|
| [13] |
JIA Keke, QIN Yanfei, YANG Shuo, ZHANG Jie.
Comparison between a lipoprotein （a） particle concentration assay and 2 kinds of lipoprotein （a） mass concentration assays
[J]. Laboratory Medicine, 2017, 32(7): 570-576.
|
| [14] |
HUANG Shengxian, ZHENG Liping, YANG Lan, LU Junjia, ZHU Xu.
Relationship of cystatin C and single nucleotide polymorphisms with coronary heart disease in Guangxi
[J]. Laboratory Medicine, 2017, 32(7): 597-602.
|
| [15] |
TANG Liping, OU Yuanzhu, WANG Meijuan, LIU Wenbin, YU Xiaoxuan, JU Yi.
Analysis on the results of external quality assessment of cystatin C in Shanghai
[J]. Laboratory Medicine, 2016, 31(8): 713-717.
|
